Issued Patents All Time
Showing 1–25 of 55 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12427347 | Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof | Jay M. Short, Gerhard Frey | 2025-09-30 |
| 12311032 | Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof | Jay M. Short, Gerhard Frey | 2025-05-27 |
| 12252535 | Antibody molecules to LAG-3 and uses thereof | Frederic Triebel, Chrystelle Brignone, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton +1 more | 2025-03-18 |
| 12187801 | Chimeric antigen receptors against AXL or ROR2 and methods of use thereof | Gregory I. Frost, James Onuffer, Jay M. Short, Gerhard Frey | 2025-01-07 |
| 12186278 | Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy | Jennifer Brogdon, Boris Engels, Gordon J. Freeman, Gerhard Frey, Jennifer Marie Mataraza +2 more | 2025-01-07 |
| 12110611 | Conditionally active biological proteins | Jay M. Short, Gerhard Frey | 2024-10-08 |
| 11897959 | Anti-AXL antibodies, antibody fragments and their immunoconjugates and uses thereof | Jay M. Short, Gerhard Frey | 2024-02-13 |
| 11879011 | Anti-ROR2 antibodies, antibody fragments, their immunoconjucates and uses thereof | Jay M. Short, Gerhard Frey | 2024-01-23 |
| 11859007 | Humanized anti-CD73 antibodies | Emily Piccione Griffin, Richard A. Miller, Gerhard Frey | 2024-01-02 |
| 11851499 | Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof | Jay M. Short, Gerhard Frey | 2023-12-26 |
| 11834472 | Anti-IL-22 antibodies, antibody fragments, their immunoconjugates and uses thereof | Jay M. Short, Gerhard Frey, William J. Boyle | 2023-12-05 |
| 11827704 | Antibody molecules to PD-1 and uses thereof | Gordon J. Freeman, Arlene H. Sharpe, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton +1 more | 2023-11-28 |
| 11773509 | Conditionally active polypeptides and methods of generating them | Jay M. Short, Gerhard Frey | 2023-10-03 |
| 11718844 | Mirac proteins | Jay M. Short, Gerhard Frey | 2023-08-08 |
| 11542332 | Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof | Jay M. Short, Gerhard Frey | 2023-01-03 |
| 11472876 | Conditionally active polypeptides | Jay M. Short, Gerhard Frey | 2022-10-18 |
| 11413340 | Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy | Jennifer Brogdon, Boris Engels, Gordon J. Freeman, Gerhard Frey, Jennifer Marie Mataraza +2 more | 2022-08-16 |
| 11292834 | Therapeutic CD47 antibodies | William A. Frazier, Pamela T. Manning, Gerhard Frey, Robert W. KARR | 2022-04-05 |
| 11279924 | Conditionally active polypeptides and methods of generating them | Jay M. Short, Gerhard Frey | 2022-03-22 |
| 11254932 | Conditionally active biological proteins | Jay M. Short, Gerhard Frey | 2022-02-22 |
| 11254742 | Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof | Jay M. Short, Gerhard Frey | 2022-02-22 |
| 11149088 | Anti-Axl antibodies, antibody fragments and their immunoconjugates and uses thereof | Jay M. Short, Gerhard Frey | 2021-10-19 |
| 11111288 | Conditionally active chimeric antigen receptors for modified t-cells | Jay M. Short, Gerhard Frey | 2021-09-07 |
| 10954288 | Modified antibody regions and uses thereof | Gerhard Frey, Jay M. Short | 2021-03-23 |
| 10851165 | Antibody molecules to PD-L1 and methods of treating cancer | Gordon J. Freeman, Arlene H. Sharpe, Gerhard Frey, Jennifer Marie Mataraza, Glenn Dranoff | 2020-12-01 |